The value of pre and postoperative Quality of life after parathyroid glands Resection in patients with hyperparathyroid.

Main Article Content

Dr. Mohammed Tareq Mohammed
Dr. Ali Mohammed Ali Ridha
Dr. Tareq Jawad kadem Al-Rubayee
Dr. Ali Tariq Thanoon Yahya
Abbas AbdulWahhab Jumaah

Keywords

hyperparathyroid; QoL, SWAL-QOL; Depression; and Dysphagia.

Abstract

Background. Hyperparathyroidism is a disease that develops with increased production of parathyroid hormone and is manifested by a violation of calcium-phosphorus metabolism


Objective. This study aims to assess the value of quality of life before and after surgery in patients with hyperparathyroidism.


Methods. In this study, the data were analyzed statistically according to the IBM SOFT SPSS 22 program Where demographic information and data for this study were collected from several different hospitals in Iraq with a study period of 2020-2021.


The results were recorded in this study according to the SWAL QOL questionnaire before surgery and 6 months after it to know the quality of life for patients.


Results


 in this study, 40 patients were collected, the ages of the patients ranged between 40-70 years, and they were distributed according to gender (male 25 with  patient (62.5%), female  were 15 patients with (37.5%),the patients were distributed according to concentration of calcium in the blood where found a statistically significant relationship was found between calcium level and quality of life before parathyroidectomy


Conclusion


We conclude from this study on the improvement of the patient's condition according to the quality of life scale, where parathyroid glands Resection  leads to an improvement in the patient's health in physical function, mental health and vital activity

Abstract 230 | pdf Downloads 67 PDF Downloads 154 XML Downloads 9 HTML Downloads 31

References

1. Howden CW. Management of acid-related disorders in patients with dysphagia. Am J Med. 2004;117(Suppl 5A):44S–48S. [PubMed] [Google Scholar]
2. Palmer JB, Drennan JC, Baba M. Evaluation and treatment of swallowing impairments. Am Fam Physician. 2000;61:2453–2462. [PubMed] [Google Scholar]
3. Lovell SJ, Wong HB, Loh KS, et al. Impact of dysphagia on quality-of-life in nasopharyngeal carcinoma. Head Neck. 2005;27:864–872. [PubMed] [Google Scholar]
4. Greenblatt DY, Sippel R, Leverson G, et al. Thyroid resection improves perception of swallowing function in patients with thyroid disease. World J Surg. 2009;33:255–260. [PMC free article] [PubMed] [Google Scholar]
5. Fraser WD. Hyperparathyroidism. Lancet. 2009;374:145–158. [PubMed] [Google Scholar]
6. Chen H, Wang TS, Yen TW, et al. Operative failures after parathyroidectomy for hyperparathyroidism: The influence of surgical volume. Ann Surg. 2010;252:691–695. [PubMed] [Google Scholar]
7. Korkis AM, Miskovitz PF. Acute pharyngoesophageal dysphagia secondary to spontaneous hemorrhage of a parathyroid adenoma. Dysphagia. 1993;8:7–10. [PubMed] [Google Scholar]
8. Shundo Y, Nogimura H, Kita Y, et al. Spontaneous parathyroid adenoma hemorrhage. Jpn J Thorac Cardiovasc Surg. 2002;50:391–394. [PubMed] [Google Scholar]
9. Maweja S, Sebag F, Hubbard J, et al. Spontaneous cervical haematoma due to extracapsular haemorrhage of a parathyroid adenoma: a report of 2 cases. Ann Chir. 2003;128:561–562. [PubMed] [Google Scholar]
10. Grieve RJ, Dixon PF. Dysphagia: A further symptom of hypercalcaemia? Br Med J (Clin Res Ed) 1983;286:1935–1936. [PMC free article] [PubMed] [Google Scholar]
11. Lila AR, Sarathi V, Jagtap V, Bandgar T, Menon PS, Shah NS. Renal manifestations of primary hyperparathyroidism. Indian J Endocrinol Metab. 2012;16(2):258–258. [PMC free article] [PubMed] [Google Scholar]
12. Shah VN, Bhadada SK, Bhansali A, Behera A, Bhattacharya A, Nahar U, et al. Effect of gender, biochemical parameters & parathyroid surgery on gastrointestinal manifestations of symptomatic primary hyperparathyroidism. Indian J Med Res. 2014;139(2):279–279. [PMC free article] [PubMed] [Google Scholar]
13. Weber T, Eberle J, Messelhäuser U, Schiffmann L, Nies C, Schabram J, et al. Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg. 2013;148(2):109–115. [PubMed] [Google Scholar]
14. Brito K, Edirimanne S, Eslick GD. The extent of improvement of health-related quality of life as assessed by the SF36 and Pasieka scales after parathyroidectomy in patients with primary hyperparathyroidism–a systematic review and meta-analysis. Int J Surg. 2015;13:245–249. [PubMed] [Google Scholar]
15. Roman SA, Sosa JA, Mayes L, Desmond E, Boudourakis L, Lin R, et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery. 2005;138(6):1121–1129. [PubMed] [Google Scholar]
16. Bannani S, Christou N, Guerin C, Hamy A, Sebag F, Mathonnet M, et al. Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg. 2018;105(3):223–229. [PubMed] [Google Scholar]
17. Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M, et al. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disor. 2019;19(1):106–106. [PMC free article] [PubMed] [Google Scholar].
18. Bollerslev J, Schalin-Jäntti C, Rejnmark L, et al. Management of endocrine disease: unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol. 2019; 181(3): P1– 19.
19. Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017; 28(1): 1– 19.
20. Shah VN, Bhadada S, Bhansali A, Behera A, Mittal BR. Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res. 2014; 139(5): 694– 9.
21. Bannani S, Christou N, Guerin C, et al. Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg. 2018; 105(3): 223– 9.
22. Storvall S, Ryhänen EM, Heiskanen I, Sintonen H, Roine RP, Schalin-Jäntti C. Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study. Hormone Metab Res. 2017; 49(10): 772– 7.
23. Ejlsmark-Svensson H, Sikjaer T, Webb SM, Rejnmark L, Rolighed L. Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: a prospective cohort study. Clin Endocrinol. 2019; 90(1): 184– 91.
24. Machado NN, Wilhelm S. Diagnosis and evaluation of primary hyperparathyroidism. Surg Clin N Am 2019;;99:649-66. [Crossref] [PubMed]
25. Zhu CY, Nguyen D, Yeh M. Who benefits from treatment of primary hyperparathyroidism? Surg Clin N Am 2019;;99:667-79.
26. Pepe J, Cipriani C, Sonato C, et al. Cardiovascular manifestations of primary hyperparathyroidism: A Narrative Review. Eur J Endocrinol 2017;177:R297-308. [Crossref] [PubMed]
27. Ejlsmark-Svensson H, Rolighed L, Rejnmark L. Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: A randomized clinical trial. J Clin Endocrinol Metab 2019;104:3223-32. [Crossref] [PubMed]

Most read articles by the same author(s)